Form 8-K - Current report:
SEC Accession No. 0001493152-25-011151
Filing Date
2025-03-21
Accepted
2025-03-21 16:15:30
Documents
52
Period of Report
2025-03-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 56100
2 ex99-1.htm EX-99.1 61277
3 ex99-1_001.jpg GRAPHIC 187400
4 ex99-1_002.jpg GRAPHIC 258569
5 ex99-1_003.jpg GRAPHIC 199502
6 ex99-1_004.jpg GRAPHIC 241892
7 ex99-1_005.jpg GRAPHIC 224498
8 ex99-1_006.jpg GRAPHIC 211695
9 ex99-1_007.jpg GRAPHIC 214711
10 ex99-1_008.jpg GRAPHIC 263207
11 ex99-1_009.jpg GRAPHIC 296658
12 ex99-1_010.jpg GRAPHIC 268113
13 ex99-1_011.jpg GRAPHIC 369285
14 ex99-1_012.jpg GRAPHIC 271050
15 ex99-1_013.jpg GRAPHIC 274114
16 ex99-1_014.jpg GRAPHIC 326175
17 ex99-1_015.jpg GRAPHIC 196586
18 ex99-1_016.jpg GRAPHIC 232049
19 ex99-1_017.jpg GRAPHIC 268552
20 ex99-1_018.jpg GRAPHIC 342879
21 ex99-1_019.jpg GRAPHIC 243711
22 ex99-1_020.jpg GRAPHIC 334956
23 ex99-1_021.jpg GRAPHIC 340902
24 ex99-1_022.jpg GRAPHIC 248038
25 ex99-1_023.jpg GRAPHIC 275966
26 ex99-1_024.jpg GRAPHIC 189351
27 ex99-1_025.jpg GRAPHIC 260028
28 ex99-1_026.jpg GRAPHIC 160283
29 ex99-1_027.jpg GRAPHIC 236042
30 ex99-1_028.jpg GRAPHIC 315201
31 ex99-1_029.jpg GRAPHIC 320140
32 ex99-1_030.jpg GRAPHIC 354437
33 ex99-1_031.jpg GRAPHIC 226697
34 ex99-1_032.jpg GRAPHIC 198670
35 ex99-1_033.jpg GRAPHIC 234331
36 ex99-1_034.jpg GRAPHIC 244163
37 ex99-1_035.jpg GRAPHIC 235015
38 ex99-1_036.jpg GRAPHIC 316864
39 ex99-1_037.jpg GRAPHIC 199562
40 ex99-1_038.jpg GRAPHIC 192569
  Complete submission text file 0001493152-25-011151.txt   13758769

Data Files

Seq Description Document Type Size
41 XBRL SCHEMA FILE anix-20250320.xsd EX-101.SCH 3006
42 XBRL LABEL FILE anix-20250320_lab.xml EX-101.LAB 34240
43 XBRL PRESENTATION FILE anix-20250320_pre.xml EX-101.PRE 22353
54 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3697
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

EIN.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-37492 | Film No.: 25760685
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)